{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5608, 
        5621
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5817, 
        5830
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5622, 
        5631
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5831, 
        5840
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5190, 
        5213
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5368, 
        5384
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7693, 
        7713
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7715, 
        7723
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5456, 
        5483
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5485, 
        5495
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5504, 
        5509
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5571, 
        5576
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5750, 
        5755
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7673, 
        7678
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        546, 
        575
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        577, 
        594
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7625, 
        7651
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7653, 
        7671
      ]
    }
  ], 
  "Negative Findings Phraseology (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5795, 
        5807
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5542, 
        5548
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5498, 
        5502
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5565, 
        5569
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5744, 
        5748
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5510, 
        5521
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5577, 
        5587
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5756, 
        5778
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7679, 
        7690
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        598, 
        600
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        1823, 
        1825
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        2243, 
        2245
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        3285, 
        3287
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        3799, 
        3800
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        3894, 
        3895
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        4225, 
        4226
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        4723, 
        4725
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5495, 
        5497
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5562, 
        5564
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5741, 
        5743
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5851, 
        5853
      ]
    }
  ], 
  "__text": "MSH|^~\\&|LABCORP-CORP|LABCORP^34D0655059^CLIA|Cancer Registry|State|201706010938|State006|ORU^R01|2017060107093839521000|P|2.3.1\nPID|1||^^^^SS^~11111111^^^^PI^|ALTERNATE ID|TEST^PATIENT^A||19500601|M||2054-5^Black or African American^CDC^^^|1234 Test Road^^ALBANY^NY^12201||^^^^^222^1234567|||||||\nORC|RE||111A1111111||||||||||||||||||Ordering Facility Name^^L|2222 W. Test Road^^Test^TX^77025|^^^^^111^1234567||\nOBR|1||111A1111111|^^^111111^Pathology Report^L|||201705301335|||||||20090115||Ordering Provider Name||||||20170530|||F|||||||\n\n\n\n\n\n\nPath report.gross observation\n\nGross description: \n A. Intraoperative Consultation:  Received: fresh  Specimen: right middle lobe  Pathologic Evaluation: frozen section  Diagnosis: Lung, right middle lobe, wedge resection: Well delineated nodule of benign lung parenchymal elements and cartilage suggestive of hamartoma  Communicated to: Dr. at 9:38 AM on 02/27/2017  Tissue submitted: 1 \n Labeled: right middle lobe \n Type of procedure: wedge \n Laterality: right \n Weight of specimen: 1 grams \n Size of specimen: 3.0 x 1.0 x 0.5 cm \n Other attached structures: a 2.2 cm long staple line \n Specimen integrity: intact \n Orientation: pleurablue and staple line removed and parenchymal margin inked green \n Number of masses: 1 \n Size(s) of mass(es): 0.4 x 0.4 x 0.2 cm \n Location of mass(es): adjacent staple line \n Description of mass(es): slightly rubbery tan \n Relationship of mass(es) to bronchus: cannot be determined \n Margins: Bronchial margin: cannot determine Parenchymal margin: 0.1 cm from inked parenchymal margin Other margins: abutting pleura \n Relationship / distance of mass(es) to pleura: abutting \n Extension of mass(es): grossly confined \n Description of remainder of lung: crepitant pink-tan \n Block summary: 1-frozen section remnant 2-remaining lung tissue \n B. Intraoperative Consultation:  Received: fresh  Specimen: right upper lobe wedge resection  Pathologic Evaluation: frozen section  Diagnosis: IOC and FSA1: lung, right upper lobe; wedge resection: No tumor seen on gross (parenchymal) margin in a representative section. Grossly 2.5-3 mm from margin. One millimeter to parenchyma by frozen section  Communicated to: Dr. at 10:27 AM on 02/27/2017  Tissue submitted: 1 \n B. Labeled: right upper lobe wedge resection \n Type of procedure: wedge \n Laterality: right \n Weight of specimen: 24 grams \n Size of specimen: 5.6 x 5.2 x 2.0 cm \n Other attached structures: a 12.0 and 3.2 cm long staple line \n Specimen integrity: intact \n Orientation: stitch marks closest margin clinically Pleura inked blue Staple line removed and parenchyma margin inked green \n Number of masses: 1 \n Size(s) of mass(es): soft ill-defined necrotic 2.1 x 1.5 x 1.5 cm \n Location of mass(es): underlying pleura \n Description of mass(es): soft ill-defined necrotic tan \n Relationship of mass(es) to bronchus: cannot be determined \n Margins: Bronchial margin: cannot be determined Parenchymal margin: grossly 0.2 from inked margin Other margins: abutting pleura \n Relationship / distance of mass(es) to pleura: abutting \n Extension of mass(es): grossly confined \n Description of remainder of lung: crepitant pink-tan \n Block summary: 1-frozen section remnant 2-4-additional perpendicular sections of mass with parenchymal margin and pleura \n C. Labeled: right upper and middle lobe lung \n Type of procedure: upper and middle lobectomy (cannot discern 2 separate lobes) \n Laterality: right \n Weight of specimen: 196 grams \n Size of specimen: 18.5 x 9.2 x 3.5 cm \n Other attached structures: 3 staple lines, 2.6, 3.1 and 15 cm long \n Specimen integrity: focally disrupted \n Orientation: staple line is removed and underlying parenchyma inked green, yellow and blue respectively \n Number of masses: none noted \n Size(s) of mass(es): none identified (see part B) \n Location of mass(es): not applicable \n Description of mass(es): none identified (see part B) \n Relationship of mass(es) to bronchus: cannot be determined in specimen \n Margins: Bronchial margin: cannot be determined in specimen Parenchymal margin: cannot be determined in specimen Other margins: cannot be determined in specimen \n Relationship / distance of mass(es) to pleura: no residual mass grossly evident (see part B) \n \n Description of remainder of lung: crepitant red tan \n Block summary: 1- 5 possible hilar lymph nodes 2- en face vascular and bronchial hilar margin 3- 4 possible hilar lymph nodes 4- one bisected lymph node 5- en face yellow parenchymal margin 6- en face green parenchymal margin 7- en face blue inked parenchymal margin 8- representative uninvolved parenchyma 9- representative hilar area with 2 additional intraparenchymal lymph nodes 10- representative peripheral uninvolved parenchyma \n D. Labeled: R4 lower paratracheal \n Tissue fragment(s): 1 \n Size: 0.6 x 0.5 x 0.1 cm \n Description: yellow lobulated fragment with what appears the lymph node \n Entirely submitted in one cassette(s). \n \n \n /XDB\n\n\nPayment procedure\n\nCPT                            .883071, 883072, 883093, 883054, 883131, 883132, 883311, 883312\n\n\nPATHOLOGIST NAME\n\nElectronically signed: Pathologist name, Pathologist\n\n\nDiagnosis ICD code\n\nPathologist provided ICD-10:C34.81, D14.31\n\n\nPath report.relevant Hx\n\nPre-operative diagnosis: Malignant neoplasm of upper lobe of right lung\nPost-operative diagnosis: Malignant neoplasm of upper lobe of right lung \n \n \n .\nClinical history: None provided \n D14.31 - Benign neoplasm of right bronchus and lung\n\n\nPath report.final diagnosis\n\nDiagnosis:A. LUNG, RIGHT MIDDLE LOBE; WEDGE RESECTION: - BENIGN HAMARTOMA. \n B. LUNG, RIGHT UPPER LOBE; WEDGE RESECTION: - SQUAMOUS CELL CARCINOMA. - TUMOR IS 1 MM FROM INKED PARENCHYMAL MARGIN. - VISCERAL PLEURA INVASION IS IDENTIFIED BY ELASTIC STAIN. \n C. LUNG, RIGHT UPPER AND MIDDLE LOBES; BILOBECTOMY: - NEGATIVE FOR RESIDUAL SQUAMOUS CELL CARCINOMA, SEE PART B. - THE SURGICAL MARGINS ARE NEGATIVE. - NO TUMOR SEEN IN 11 LYMPH NODES. - SEE SUMMARY BELOW. \n Note: The control slide stained appropriately. \n \n Specimens InvolvedB: Right upper lobe C: Right upper and middle lobe of lung D: R-4 lower paratracheal \n LUNG: Resection SPECIMEN Specimen: Lobe(s) of lung (specify) Upper and middle Procedure:   Other (specify) Right upper and middle lobectomy Specimen Integrity: Intact Specimen Laterality:   Right Tumor Site:  Upper lobe Middle lobe Tumor Focality:   Unifocal TUMOR Histologic Type:  Squamous cell carcinoma EXTENT Tumor Size:  Greatest dimension (cm) 2.1cm Visceral Pleura Invasion:   Present Tumor Extension:  Not applicable MARGINS Bronchial Margin:  Uninvolved by invasive carcinoma and carcinoma in situ Vascular Margin:  Uninvolved by invasive carcinoma Parenchymal Margin: Uninvolved by invasive carcinoma ACCESSORY FINDINGS Lymph-Vascular Invasion: Not identified STAGE (pTNM) Primary Tumor (pT): pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest dimension surrounded by lung or visceral pleura without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus); or Tumor 5 cm or less in greatest dimension with any of the following features of extent: involves main bronchus, 2 cm or more distal to the carina; invades the visceral pleura; associated with atelectasis or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung Regional Lymph Nodes (pN) pN0: No regional lymph node metastasis Number of Lymph Nodes Examined:  Specify 11 Number of Lymph Nodes Involved:  None identified Distant Metastases (pM): Not applicable \n \n XDB/03/03/2017 **********************************************************************\n\n\nPath report.site of origin\n\nMaterial submitted: Right middle lobe\n\n\nPath report.comments\n\nComment:CASE: PATIENT: Final Diagnosis performed by Electronically signed 3/3/2017 1:09:16PM \n \n \n The electronic signature indicates that the named Attending Pathologist has evaluated the specimen \n Technical component performed at LabCorp, 1447 York Court, Burlington, NC 27215 Lab: 800-762-4344 Dir: William F. Hancock, MD \n Professional component performed at LabCorp, Alamance Regional Medical Center, 1240 Huffman Mill Rd, Burlington, NC 27215 Lab: 336-538-7833 Dir: Tara C. Rubinas, MD .\n\n\n"
}